Hummingbird Diagnostics announces publication of miLung small RNA-based blood test data for early detection of lung cancer
Hummingbird Diagnostics GmbH, a leader in reading blood-based small RNAs for early disease detection and…
Hummingbird Diagnostics GmbH, a leader in reading blood-based small RNAs for early disease detection and…
Tempus, a leader in artificial intelligence and precision medicine, introduces its standalone RNA next-generation sequencing assay, Tempus…
RealSeq Biosciences has developed a targeted removal probe (Selective Suppression Probe- SSP) approach to deplete undesired…
MGI, a company committed to building core tools and technology to lead life science, announced…
Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA…
Investigators from Baylor College of Medicine (BCM) in collaboration with Immunai have published results from a clinical…
TATAA Biocenter, a leading CRO of molecular analysis services, announces it has become a certified service…
New research shows that a CRISPR-based depletion technology overcomes the limitations of past NGS pandemic…
Brain metastases in patients with kidney cancer may have immune-suppressive tumor microenvironments Researchers applied single-nucleus…
New panel leverages Anchored Multiplex PCR (AMP) chemistry and Archer Analysis to detect fusions, splice variants…